Johnson booster 85% effective against Omicron: S.Africa study
Chinese officials promise groceries for lockdown residents
30 December 2021Rivaroxaban as thromboprophylaxis improves clinical outcomes after COVID-19 hospitalization
30 December 2021Johnson booster 85% effective against Omicron: S.Africa study
A booster of US coronavirus vaccine Johnson & Johnson was 85 percent effective in preventing serious illness in areas where Omicron was dominant, a South African trial study indicated Thursday.
